About this policy
This article is the response to comments received by Noridian Healthcare Solutions regarding the proposed Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s and Non-Hodgkin’s Lymphoma with B-Cell or T-Cell Origin. The comment period began on 08/04/2022 and was presented at the 08/25/2022 Open Public Meeting. The Comment period ended on 09/17/2022. The notice period begins on 01/19/2023 and ends on 03/04/2023. The LCD becomes final on 03/05/2023. All comments were reviewed, and the responses are provided in this document.
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.